Duloxetine is an antidepressant, with a specific batch having been recalled due to the presence of potentially cancer-causing impurities.

According to the FDA, the medication had the "presence ... 2018 because they contained nitrosamines. The recent recall covered duloxetine drugs made by New Jersey-based company Rising ...

The capsules of duloxetine were first recalled in November, but the FDA recently categorized the recall as a Class II risk, a situation in which "use of or exposure to a violative product may ...

bottles of duloxetine have been recalled due to potentially containing high levels of cancer-causing impurities.

In October, The FDA initially announced a Class II recall for just 7,107 bottles of duloxetine capsules distributed by Towa Pharmaceutical Europe. According to the FDA, 233,003 bottles have been ...

The FDA issued a voluntary recall of the company’s product on Nov. 19. In three separate reports, the FDA said that various doses of duloxetine delayed-release capsules were recalled due to the ...

The prescription drug Cymbalta, generically duloxetine, is under recall for cancer-causing impurities that may have occurred ...

The FDA had initially recalled about 7,100 bottles of duloxetine in October for the cancer-causing chemical. Last month, the agency expanded the recall to include capsules produced by New Jersey ...

FDA recalls over 200,000 duloxetine bottles due to N-nitroso-duloxetine contamination, increasing cancer risk.

The capsules of duloxetine were first recalled in November, but the FDA recently categorized the recall as a Class II risk, a situation in which "use of or exposure to a violative product may cause ...